Content Type: Research Publications

Therapeutic Benefit of Top-Selling Oncology Drugs in Medicare

March 6, 2026

Primary Medication Adherence in Medicare Beneficiaries Prescribed Sacubitril-Valsartan or Renin-Angiotensin System Blockers for Heart Failure with Reduced Ejection Fraction

March 6, 2026

Pediatric Exclusivity Revenues for Cancer Drugs

March 6, 2026

Accelerating Biosimilar Market Access: The Case for Allowing Earlier Standing

March 6, 2026

Academic Detailing Interventions and Evidence-Based Prescribing: A Systematic Review

March 6, 2026

Characteristics of Trials Preceding FDA Approval of Novel Psychiatric Drugs

March 6, 2026

A Regulatory Roadmap for Repurposing: Comparing Pathways for Making Repurposed Drugs Available in the EU, UK, and US

March 6, 2026

Regulatory Flexibilities Balancing Unmet Needs, Benefits and Risks in the Approvals of Imported Cancer Drugs in China: a Cohort Study From 2012 to 2021

March 6, 2026

Physician-Patient Communication About Novel Drugs and High-Risk Medical Devices

March 6, 2026

Government Funding for the Development of Enzalutamide

March 6, 2026

Financial Challenges of Being on Long-Term, High-Cost Medications

March 6, 2026

Predicting Patent Challenges for Small-Molecule Drugs: A Cross-Sectional Study

March 6, 2026